Work

A Phase 1/2 Study of a ROR1-Targeting CAR T Cell Therapy (ONCT-808) in Adult Patients with Relapsed/Refractory (R/R) Aggressive B Cell Lymphomas (BCL)

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-200998

Authors: Michael Wang, Patrick Connor Johnson, Salim Yazji, Yisrael Katz, Angela Pietrofeso, James Robinson, Matthew Mei, Matthew J. Frigault, James B. Breitmeyer, Caron A. Jacobson

Institutions: The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital, City Of Hope National Medical Center, City of Hope, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405040729

Cites:

Cited by: 5

Related to: 10